Vaxxinity, Inc.Vaxxinity, Inc.Vaxxinity, Inc.

Vaxxinity, Inc.

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−0.10USD
Revenue estimate
Market capitalization
‪15.39 M‬USD
−0.4502USD
‪−56.93 M‬USD
‪45.31 M‬
Beta (1Y)
2.65

About Vaxxinity, Inc.

CEO
Mei Mei Hu
Headquarters
Exploration Park
Employees (FY)
57
Founded
2014
FIGI
BBG00ZWVMKJ9
Vaxxinity, Inc. is a biotechnology company that aims to democratize health by bringing the efficiency of vaccines to chronic diseases. The company uses its synthetic peptide vaccine platform to harness the immune system and convert the body into its own 'drug factory', stimulating the production of antibodies with a therapeutic effect. Its current pipeline consists of five chronic disease candidates from early to late-stage development across multiple therapeutic areas including Alzheimer’s, Parkinson’s, migraine and hypercholesterolemia as well as a candidate for COVID-19 prevention. The company was founded by Louis G. Reese IV and Mei Mei Hu in 2014 and is headquartered in Exploration Park, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VAXX is 0.1166 USD — it has decreased by 3.95% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Vaxxinity, Inc. stocks are traded under the ticker VAXX.
Vaxxinity, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
VAXX stock is 16.28% volatile and has beta coefficient of 2.65. Check out the list of the most volatile stocks — is Vaxxinity, Inc. there?
VAXX earnings for the last quarter are −0.10 USD per share, whereas the estimation was −0.11 USD resulting in a 9.09% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about Vaxxinity, Inc. earnings.
Yes, you can track Vaxxinity, Inc. financials in yearly and quarterly reports right on TradingView.
VAXX stock has fallen by 75.71% compared to the previous week, the month change is a 82.85% fall, over the last year Vaxxinity, Inc. has showed a 94.42% decrease.
VAXX net income for the last quarter is ‪−11.39 M‬ USD, while the quarter before that showed ‪−13.15 M‬ USD of net income which accounts for 13.34% change. Track more Vaxxinity, Inc. financial stats to get the full picture.
Today Vaxxinity, Inc. has the market capitalization of ‪15.39 M‬, it has decreased by 38.70% over the last week.
No, VAXX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VAXX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Vaxxinity, Inc. stock right from TradingView charts — choose your broker and connect to your account.
VAXX reached its all-time high on Nov 11, 2021 with the price of 22.7700 USD, and its all-time low was 0.1075 USD and was reached on Apr 26, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has 57.00 employees. See our rating of the largest employees — is Vaxxinity, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Vaxxinity, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Vaxxinity, Inc. stock shows the strong sell signal. See more of Vaxxinity, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.